Plug-N-Go is a company that provides electric vehicle charging infrastructure with the aim of sustainably electrifying transport. The company has 24 charge points that are accessible to users via its app. It sources 100% renewable energy from its partners at Octopus Energy. Air pollution is contributing to 40,000 early deaths a year in the UK that Plug-N-Go is striving to change. The global electric vehicle charging stations market will reach USD 27.7 billion by 2027 from an estimated USD 2.5 billion in 2019. The company hopes to become a strong contender in this segment. Plug-N-Go is in discussions over multi-site agreements with the Co-operative Society and Eden district council and has received interest from Associated British Ports. Its goal is to install 3,800 EV charge points for the public in 5 years at sites where drivers are already parking. The company will use the investment to deliver EV charging stations to businesses across the UK.
days to go:
Expired
investment:
£176,008
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
Alyve provides personalised subscription nutrition powered by Artificial Intelligence (AI). It argues that 8.2 million UK vitamin users are looking for personalised nutrition in one capsule. Alyve asserts that its product can fulfil this demand. Users complete a 3-minute questionnaire where their responses are recorded by Alyve's intelligent algorithms. These then, based on the responses, help the user select one of Alyve's nutritional pills best matched to their goals and needs. Alyve then delivers the pills to the user's doorstep every 30 days. The company has recorded 4000+ questionnaires and completed 800+ orders in 25 countries since Q4 of 2020. It aims to become a contender in the $21 billion supplement market. The company will use the investment received to increase marketing efforts, transform Alyve into a household brand, introduce new product lines, increase staff, improve technology, and transform both digital and physical User Experiences (UX).
days to go:
Expired
investment:
£227,782
The Fitfck application (parented by The Social Station Media Group) is a fitness dating app designed to connect like-minded fitness enthusiasts within a socially isolating lifestyle. The app is based on the founders' experience and has been described as 'The UK's fastest-growing fitness social app' by Google, London. The company witnessed 100,000 sign-ups in its first year at a cost per install of £0.30 (Industry average £1.20), has working relationships with Google, Facebook and YouTube, and is available to interested franchisees in 30+ countries. The application has 60,000+ followers across social media handles such as Instagram, Facebook, and Twitter. It has been featured in publications such as Daily Mail, Metro, and London Loves Business. It will use the investment to pay salaries to its staff, increase marketing initiatives, manage server costs, and other expenses.
days to go:
Expired
investment:
Withheld
FLY LDN is a fitness brand that imparts sports and fitness instruction via its digital platform and its studios in central London and Fitzrovia. The company launched its video-on-demand and live-streaming fitness platform, FLY LDN Online (FLO), in September 2020. It asserts that within six months of launch, FLO scaled over 28,000 monthly views across 80+ countries with users having viewed over 2.5 million minutes of FLY LDN workouts. FLY LDN won the Men's Health 'Best Studio 2019' award and was commended at the 2018 and 2019 Tatler Gym Awards. The company has also received press coverage in publications like Women's Health, Forbes, Esquire, Elle, Vogue, GQ and Glamour. It has also partnered with brands such as DKNY and ASOS. FLY LDN aspires to become a contender in the global online fitness market that is expected to reach $59 billion by 2027. The company will use the investment to further develop additional functionality and TV apps for FLO and fund marketing campaigns to fuel growth.
days to go:
Expired
investment:
£340,928
HealthBox Software is a technology company building products for the post-COVID healthcare landscape. Its first product, ClearPass, was met with success. The tool asks an employee a series of screening questions related to COVID-19, including evidence of fever, fatigue, and dry cough, etc. ClearPass has over 400,000 end-users including companies like Johnson Controls, Remy Cointreau and the San Diego School District. HealthBox aims to be a significant contender in the global digital health market that is expected to be worth $600 billion by 2026. The company is on the verge of launching another innovative product, MyHealthBox. It is a consumer-facing digital health app that will allow users to store their medical records, easily accessible 24/7. HealthBox asserts that the app will have an array of features, including AI health assessment services, dietary advice and data-powered lifestyle guidance. The company will use 47% of the investment towards technology and development costs, and 53% towards sales and marketing.
days to go:
Expired
investment:
£144,265
Advanced Blast & Ballistic Systems (ABBS) is a company that has developed globally patented systems to counteract the forces an armoured vehicle sustains when a mine or Improvised Explosive Device (IED) explodes under it. As per reports, mines and IEDs accounted for over 80% of UK and US army casualties in Iraq & Afghanistan. ABBS believes that its products can keep occupants inside a vehicle completely safe from the aforementioned explosive devices. The armoured vehicle protection market has a value of about $20 billion wherein ABBS aims to be a major contender. The company has received £2 million-plus revenues till date from Research and Development (R&D) grants in the UK, as well as, sold its products to the US Army and Israel with profits worth £145,000 in 2018 and £560,000 in 2019 respectively. It will use the investment to bring its products to more markets globally.
days to go:
Expired
investment:
£445,814
Thalamos is a software solution for completing the Mental Health Act (MHA) forms digitally, across any device. It aims to help those with acute mental illness access care quickly reducing treatment time from 7 days to 27 hours. The company delivers SaaS (Software-as-a-Service) to National Health Service (NHS) Trusts, local authorities and private mental healthcare providers. It also works directly with the UK healthcare regulator, The Care Quality Commission (CQC). Thalamos has over £500,000 of investment raised till date. Pre Covid-19, the company was already working with the CQC and supported them in safely submitting their statutory forms to hospitals across the country. Over 75% of NHS Trusts have received Thalamos' MHA forms in the last 60 days. The company will use 48% of the investment for product development, 20% for customer on-boarding, 16% for business development, and 16% as working capital.
days to go:
Expired
investment:
£290,278
Antaco is a company that deals in waste management by converting it into neutral solid biofuel using their patented technology. The global water sector is estimated to present a £15 billion opportunity. To date, the company has raised £5.8 million, including an £857,000 grant from the UK government and has also signed a contract with its first customer (Swiss Public Utility). With the proceeds, the company will build up their in-house capacity, increase enhancement of existing plant and hire subcontractors to install and commission plant.
days to go:
Expired
investment:
£570,840
TOTM makes organic, eco-friendly & reusable period care products. The company is planning to shake up the £29 billion Femcare industry, with 30k+ online and subscription customers, and listings in Tesco, Superdrug and Urban Outfitters and global B2B clients. Having supplied to large corporates including several global institutions, TOTM is ready for global disruption. To this end, the company is raising funds to accelerate global growth across all channels. The proceeds will also be used to expand its product range, grow awareness, secure more distribution and also invest in tech.
days to go:
Expired
investment:
£811,400
